title: Melphalan desensitization following immediate hypersensitivity in a patient undergoing conditioning for autologous hematopoietic cell transplantation.
authors.affiliation: Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pa. Electronic address: alex.ganetsky@uphs.upenn.edu.
authors.forename: Alex
authors.initials: A
authors.lastname: Ganetsky
authors.affiliation: Section of Allergy and Immunology, Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Takach
authors.affiliation: Division of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Mass.
authors.forename: Donna-Marie
authors.initials: DM
authors.lastname: Lynch
authors.affiliation: Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pa.
authors.forename: Tracy M
authors.initials: TM
authors.lastname: Krause
authors.affiliation: Section of Allergy and Immunology, Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
authors.forename: Jiah S
authors.initials: JS
authors.lastname: Teh
authors.affiliation: Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Stadtmauer
authors.affiliation: Division of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Mass.
authors.forename: Mariana
authors.initials: M
authors.lastname: Castells
authors.affiliation: Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
authors.forename: Brendan M
authors.initials: BM
authors.lastname: Weiss
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects; D003888:Desensitization, Immunologic / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D019172:Transplantation Conditioning / Q000009:adverse effects* / Q000379:methods; D014182:Transplantation, Autologous / Q000379:methods; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan